The prestigious ranking provides a data-driven look at the most successful companies within the economy’s most dynamic segment—its independent, entrepreneurial businesses. The Inc. 5000 class of 2024 represents companies that have driven rapid revenue growth while navigating inflationary pressure, the rising costs of capital, and seemingly intractable hiring challenges.
Impact Advisors adds this latest honor to a growing list of awards that includes services recognized among Best in KLAS® for 17 consecutive years, a culture designated “Best Place to Work” by Modern Healthcare for 15 years, and a firm named “America’s Best Management Consulting Firm” by Forbes for 8 consecutive years. Impact Advisors was also recently named to Crain’s Chicago Business 2024 “Fast 50” list ranking the fastest-growing Chicagoland companies based on five-year growth.
About Impact Advisors
Impact Advisors is a leading healthcare management consulting firm committed to solving the industry’s emerging and evolving challenges. Our high-performing team of clinical, financial, operations and technology experts collaborate to architect quality solutions and deliver measurable value for our clients. We are the most awarded consulting firm in healthcare, with services recognized among Best in KLAS® for 17 consecutive years and a culture designated “Best Place to Work” by Modern Healthcare for 15 years. To learn more about our service quality and innovative culture, visit www.impact-advisors.com.
The Inc. 5000 class of 2024 represents companies that have driven rapid revenue growth while navigating inflationary pressure, the rising costs of capital, and seemingly intractable hiring challenges. Among this year’s top 500 companies, the average median three-year revenue growth rate is 1,637 percent. In all, this year’s Inc. 5000 companies have added 874,458 jobs to the economy over the past three years.
About The Stepping Stones Group
The Stepping Stones Group is a leading provider of therapeutic and behavioral services to children including those with special needs and autism. The company serves more than 1,200 clients and 350,000 children nationwide. With over 30 years of experience, our team consists of more than 11,000 employees including licensed clinicians and special educators, dedicated to delivering high-quality therapeutic and behavioral services. For more information: https://thesteppingstonesgroup.com/.
About Inc. 5000
For complete results of the 2024 Inc. 5000, including company profiles and an interactive database that can be sorted by industry, location, and other criteria, go to www.inc.com/inc5000.
“Being honored on the Inc. 5000 list for three consecutive years is a testament to our ability to push boundaries and seize opportunities in the ever-evolving RCM industry. I am incredibly proud of our team’s unstoppable drive and innovative spirit that have propelled 4D Global to new heights. We remain committed to providing value to our clients and revolutionizing the medical billing space.”
Making the Inc. 5000 list for three consecutive years is only possible by retaining current clients while also attracting new ones. As a leader in the medical billing industry, 4D Global consistently delivers results through strategic use of innovative technology paired with an offshore staff of 400+ seasoned professionals for optimal efficiency. 4D Global offers a full spectrum of RCM services including denial management, payment posting, coding and credentialing.
4D Global ranked 117 in the Human Resources category, 142 in the Miami–Fort Lauderdale–Pompano Beach, FL area, and 322 in Florida. This is their third time on the list.
The Inc. 5000 class of 2024 represents companies that have driven rapid revenue growth while navigating inflationary pressure, the rising costs of capital, and seemingly intractable hiring challenges. Among this year’s top 500 companies, the average median three-year revenue growth rate is 1,637 percent. In all, this year’s Inc. 5000 companies have added 874,458 jobs to the economy over the past three years.
“One of the greatest joys of my job is going through the Inc. 5000 list,” says Mike Hofman, who recently joined Inc. as editor-in-chief. “To see all of the intriguing and surprising ways that companies are transforming sectors, from health care and AI to apparel and pet food, is fascinating for me as a journalist and storyteller. Congratulations to this year’s honorees, as well, for growing their businesses fast despite the economic disruption we all faced over the past three years, from supply chain woes to inflation to changes in the workforce.”
More about Inc. and the Inc. 5000
Methodology
Companies on the 2024 Inc. 5000 are ranked according to percentage revenue growth from 2020 to 2023. To qualify, companies must have been founded and generating revenue by March 31, 2020. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2023. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2020 is $100,000; the minimum for 2023 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Growth rates used to determine company rankings were calculated to four decimal places.
About Inc.
Inc. Business Media is the leading multimedia brand for entrepreneurs. Through its journalism, Inc. aims to inform, educate, and elevate the profile of our community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating our future. Inc.’s award-winning work achieves a monthly brand footprint of more than 40 million across a variety of channels, including events, print, digital, video, podcasts, newsletters, and social media. Its proprietary Inc. 5000 list, produced every year since its launch as the Inc. 100 in 1982, analyzes company data to rank the fastest-growing privately held businesses in the United States. The recognition that comes with inclusion on this and other prestigious Inc. lists, such as Female Founders and Power Partners, gives the founders of top businesses the opportunity to engage with an
About 4D Global
4D Global is an award-winning international organization that offers customized Revenue Cycle Management (RCM) solutions for North American-based medical billing companies, healthcare software companies, hospitals and select private medical practices. 4D Global provides streamlined RCM services that improve the efficiency of medical billing operations by combining offshore talent with cutting-edge technology, automation and AI.
4D Global’s strategic partnerships provide more accurate billing, optimized processes and improved financial outcomes, resulting in increased revenue and profitability. Headquartered in Scottsdale, AZ with offices in Boca Raton, FL and Chennai, India, 4D Global has been listed in the Inc. 5000 for three consecutive years as one of the Fastest Growing Companies in the US by Inc. Magazine. They have also been Great Place To Work certified since 2021 and recognized as one of India’s Best Workplaces for Women, India’s Great Mid-Size Workplaces and more. Visit www.4dglobalinc.com to learn how we’re transforming RCM in the healthcare industry.
Media Contact
Piper Schad, 4D Global Inc, 1 800.508.9890, [email protected], 4D Global Inc
“We are excited about the fresh, new ideas and perspectives these investigators bring to leukemia research,” said Kevin Radelet, executive director. “They are some of the best and brightest young scientists in the field, selected from a highly competitive pool of applicants. Research is the center of our mission, and by funding groundbreaking projects across all types of leukemia, new treatments are being pioneered. As those discoveries happen, each one is moving us closer to a cure.”
Innovative projects
The Leukemia Research Foundation’s competitive, peer-reviewed program funds innovative projects from early-career investigators who propose research that can lead to scientific breakthroughs.
This year’s research projects span a range of topics to advance discoveries in:
Cancer cell biology, including T cell leukemias
Treatments, including immunotherapies
Causes and risk factors, including those of myelodysplastic syndrome (MDS), Richter transformation, and genetically based therapy resistance
The New Investigator Research Grant recipients for 2024-2026 are included below, and specific details about their background and projects can be found on our website.
Shruti Bhatt, PhD, Assistant Professor – Emory University
Franco Izzo, PhD, Assistant Professor – Icahn School of Medicine at Mount Sinai
Nadia Kershaw, D. Phil., Laboratory Head – Walter and Eliza Hall Institute of Medical Research – Victoria, Australia
Shan Lin, PhD, Principal Investigator – Seattle Children’s Hospital
Ioanna Mosialou, PhD, Assistant Professor – Columbia University Medical Center
Santhosh K. Pasupuleti, PhD, Assistant Research Professor – Indiana University
Elisa ten Hacken, PhD, Assistant Professor – Weill Medical College of Cornell University
Alejandro Villarino, PhD, Assistant Professor – Sylvester Comprehensive Cancer Center/University of Miami Health Systems
Eric Wang, PhD, Assistant Professor – The Jackson Laboratory for Genomic Medicine
Peer-reviewed process
The Foundation is grateful to the 24 physician-scientists and researchers from prominent medical institutions around the world who participated in this year’s grant review. The panel evaluated the proposals using similar methodology to that used by the National Institutes of Health (NIH). Led by Justin Kline, MD, professor of medicine, University of Chicago Medicine, the review process culminated in the recommendation of nine projects for funding.
To learn more about the Leukemia Research Foundation’s New Investigator Research Grant Program and the deadlines for the 2025 grant program, visit leukemiarf.org/research.
About the Leukemia Research Foundation
The Leukemia Research Foundation, headquartered in Northfield, Illinois, is committed to funding innovative leukemia research worldwide and supporting people affected by leukemia. Since its founding in 1946, more than $90M has been raised to pursue better treatments and the ultimate cure for leukemia. As the nation’s largest nonprofit focused exclusively on funding leukemia research, the Leukemia Research Foundation has invested millions in more than 600 research projects worldwide to accelerate the development of new and better treatments.
Joe Gasque, CEO of MedShift, expressed his excitement about Dr. Boyette’s appointment, stating, “Randi Boyette brings unparalleled expertise and a proven track record of driving growth and innovation. Her leadership will be instrumental in advancing Be Her’s mission to elevate women in aesthetics through education and training, and the experience she will share with the community will make a significant impact on their business growth.” Be Her is a pioneering community of businesswomen in aesthetics. With hundreds of members across the United States, Be Her represents a broad range of industry experience. From seasoned professionals to newcomers from other medical backgrounds, Be Her provides unparalleled resources including hands-on injector training, business knowledge, community networking, and mentorship opportunities. Sean Shapiro, CCO of MedShift, states “Joining Be Her is free and unlocks a world of possibilities. We believe in ‘Beauty Without Boundaries,’ and are committed to breaking down barriers in the aesthetic industry by building a supportive community. Members have access to all injectable supplies, exclusive trainings, increased savings, and valuable educational resources. Our partnership with Dr. Boyette further solidifies Be Her’s dedication to helping our members grow and succeed.”
In addition to her role at Be Her, Dr. Boyette will also serve as the Strategic Growth Advisor for MedShift, the cutting-edge technology company behind Be Her. MedShift is renowned for its solutions that drive growth and efficiency for manufacturers and healthcare providers, supporting over 4,600 active customers through its comprehensive business lines, including device subscription financing, IoT product offerings, enterprise software, and an extensive online marketplace.
About Be Her: Be Her is an empowerment initiative focused on fostering leadership, innovation, and empowerment for women in the aesthetics industry. With hundreds of members across the United States, Be Her provides unparalleled resources including hands-on injector training, business knowledge, community networking, and mentorship opportunities.
About MedShift: MedShift is a technology company founded in 2015, headquartered in Charlotte, NC, specializing in advanced solutions for the healthcare industry. MedShift’s mission is to drive growth and efficiency for manufacturers and healthcare providers through technology and software as a service.
Dr. Rathmell is an accomplished physician-scientist, from treating patients with kidney cancer to conducting research that has advanced how scientists understand the molecular and genetic drivers of the disease. Her genomic studies have led to the identification of new molecular biomarkers to help detect and treat kidney cancers earlier. In addition to publishing hundreds of scientific articles about her research studies, Dr. Rathmell has also published on ethical issues such as cancer drug shortages and conflicts of interest in scientific publishing. Beyond her research interests, she is deeply committed to mentoring and developing the next generation of physician–scientists.
The conversation between Dr. Emens and Dr. Rathmell will cover a range of topics including expanding infrastructure for cellular therapies, multi-stakeholder engagement and advice for female scientific leaders. This exchange aims to provide valuable insights and allow attendees to understand the NCI’s future and its role in ending the disease of cancer.
Visit http://www.sitcancer.org/2024 for the latest updates and to register for SITC’s 39th Annual Meeting & Pre-Conference Programs, being held from Nov. 6–10, 2024, at the George R. Brown Convention Center in Houston, TX. Virtual participation is also available. Visit http://www.sitcancer.org for more information on this event and other SITC resources.
SITC 2024 attendees will:
Participate in key scientific sessions focused on a variety of basic-, translational- and clinical-focused topics from leaders in the field
Learn about cutting-edge research with over 1,400 oral abstract presentations and poster presentations
Engage with industry representatives and learn about the latest technological advances in our exhibit hall
Earn continuing education credits
Connect with other SITC 2024 attendees from around the world
About SITC
Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on X, LinkedIn, and YouTube.
San Diego Business owner and philanthropist David Malcolm is pleased to announce that Trevor VanSkiver is the most recent recipient of the David Malcolm Scholarship
SAN DIEGO, Aug. 13, 2024 /PRNewswire-PRWeb/ — Created in 2021, the David Malcolm Scholarship is intended to provide financial assistance to students who face economic, social, or personal challenges that may stand in the way of their academic and career success.
The $2,500 scholarship is awarded to a high school senior or college student based on academic achievement and a personal essay. The essay must highlight how the award will help the student on his or her educational and career paths. The essays are also intended to inspire others with their stories.
Trevor VanSkiver is the recipient of the scholarship for Spring 2024. His moving essay recalled his battle with acute lymphoblastic leukemia. Diagnosed as a child, Trevor shared how cancer influenced his worldview and led him to a path of service to others. The experience inspired Trevor and his father to co-found the Dream Team, an endurance racing team.
The father-son endeavor raised enough money to fund 20 wishes through the Make-A-Wish Foundation.
Trevor’s philanthropy doesn’t stop there. He also volunteers with an organization called Billy Bear Hug, which provides teddy bears and other comfort items to young children with chronic illnesses. Trevor’s lifelong goal is to work in the medical field so he can help others whose lives have been impacted by disease.
David Malcolm founded the scholarship to assist students like Trevor. Having grown up in an underprivileged household, Malcolm has a special understanding of the obstacles people may face to achieve their dreams. His success in the business world inspired him to help others persevere and meet their goals.
As a philanthropist, Malcolm understands the ripple effect that occurs when one person helps another. By making Trevor’s educational path a little easier, more deserving people are likely to receive the compassion and encouragement they need to persevere during difficult times.
The David Malcolm Scholarship was originally awarded annually. This year, for the first time, it will be awarded in spring and in fall. To be eligible, applicants must be high school seniors, or have been accepted to or enrolled in an accredited college or university. All applicants must have a minimum GPA of 3.5 and submit a personal essay that might inspire others.
To learn more about this scholarship opportunity, visit the David Malcolm Scholarship website.
About David Malcolm David Malcolm is a San Diego-based entrepreneur, real estate expert, and community leader. Having a long and successful career in real estate, he believes deeply in giving back. Among his various philanthropic endeavors, he is most passionate about helping provide higher education opportunities to youth and assisting the homeless in getting their lives back on track. He and his wife Annie also support two San Diego gymnasiums and other charitable non-profits.
Jhin’s Bitters Releases a Non-Alcoholic, Wellness-Backed Alternative to Traditional Bitters
LOS ANGELES, Aug. 13, 2024 /PRNewswire-PRWeb/ — Jhin’s Bitters, a Korean American woman-owned company, proudly announces the August launch of its highly anticipated product: a revolutionary non-alcoholic alternative to traditional bitters, uniquely designed to enhance gut health. Available in their online store, this groundbreaking supplement is poised to challenge and transform norms in the wellness industry.
Featuring a meticulous blend of high-quality bittering roots, prebiotics, probiotics, collagen, and antioxidants, Jhin’s Bitters helps support digestion and promote skin health to produce a comprehensive beauty regimen. This thoughtful combination provides a comprehensive approach to well-being, nurturing your body from the inside out.
A gluten-free, sugar-free, and zero-calorie alternative to traditional cocktail mix-ins, Jhin’s Bitters prioritizes health without compromising on taste. With its ingredients rich with Asian influences, these bitters offer a sophisticated finishing touch to your favorite beverages, whether they brighten your mocktails, provide a zesty boost to sparkling water, or serve as a standalone health enhancer.
Crafted without alcohol, Jhin’s Bitters redefines your daily drink choices, seamlessly incorporating premium ingredients to support your health goals. This new product helps mocktail enthusiasts embrace a new standard of gut health support and culinary creativity while supporting vitality and holistic nourishment.
Transform your wellness routine with Jhin’s Bitters and discover the magic of harmonizing gut health, radiant skin, and a refreshing taste experience all in one innovative solution.
For more information about Jhin’s Bitters, check out their website.
About Jhin’s Bitters: Based in Los Angeles, California, Jhin’s Bitters is a pioneering brand committed to advancing health and beauty through its unique non-alcoholic bitters, setting a revolutionary benchmark in the industry. Jhin’s Bitters encapsulates the essence of wellness innovation, striving to redefine the standards of gut health with a forward-thinking, non-alcoholic offering. Discover the future of gut health with Jhin’s Bitters — beauty from the inside out!
Longtime friend Matt Christopherson, who is also Co-Founder of modern health company Opscotch, answered the call. “It was so heart wrenching to hear that a friend who had devoted 13 years of her life to pro sport was faced with such sudden health adversities,” he says. “I knew I needed to put myself out there to support her and her family.”
On September 6, Matt will run across the Sea to Sky Highway from Vancouver to Whistler, B.C., a grueling and scenic 125 km route that covers 1,900 metres of elevation. He’ll run through the night for approximately 20 hours, aiming to cross the grand finish just before cyclists participating in the RBC GranFondo on the same day. The funds raised in support of Christopherson’s run will help to change the trajectory of Temple’s healing.
“We were moved by this inspirational story the minute we heard about Krista’s recent health adversities and Matt’s response, and knew we needed to get involved officially,” says Neil McKinnon, CEO, RBC GranFondo Whistler. “We are thrilled to support a cause that rallies behind elite and Olympic athletes after they’ve transitioned out of sport.”
Temple is a true Canadian rowing legend; a two-time Olympian who won a Silver Medal in the 2012 Women’s 8. “She represented our country, and now it’s time that people show up and represent for her,” says sister Leah Guloien, who was also the first woman cyclist to win the inaugural GranFondo Whistler event. After training their whole lives for the podium, many retiring elite athletes are left without support and employment opportunities, leading to emotional, practical, and financial challenges. Temple discusses this in her book, Beyond the Finish Line: What Happens when the Endorphins Fade, highlighting the support needed to navigate post-Olympic life.
This became the inspiration for the first iteration of Project 125. Beginning with this initial fund- and awareness-raising run, Christopherson aims to build a long-term legacy of support for athletes facing sudden health adversities beyond the finish line. Additional support for this first run has been pledged by leading lifestyle and performance brands, including Reigning Champ, HOKA, Myodetox, Maurten, LMNT, and more. Christopherson is also an ambassador for local Vancouver running store The Run Inn.
“Fighting on your own sucks,” says Temple. “That collective effort is so inspiring. It’s what got me here today, and can help others continue to fight too.”
Learn more and donate at project125.ca.
ABOUT PROJECT 125 Project 125 is building a legacy of support to help athletes facing sudden health adversities, providing funding beyond the finish line.
Karen E. Todd, RD, CSCS, EP-C, CISSN, and Vice President of Global Marketing at Kyowa Hakko U.S.A., Inc., said, “In our dynamic industry, delivery systems that present consumers with science-backed ingredients like Cognizin® in an effective, functional, and fun formulation such as Smart Chocolate BPC-157 are changing the face of the dietary supplement industry.”
Driven by people’s increasing interest in brain health supplements, the global market for these supplements was valued at USD 8.63 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 13.3% by 2030.
“With so many consumers looking for less traditional ways to improve their brain health experience, it’s exciting to collaborate with branded ingredients like Cognizin® to help support our mission of results-driven formulations,” said InfiniWell’s VP Dr. Adam Killpartrick.
This guilt-free dark chocolate-cherry treat is perfect for health enthusiasts, nutritionists, and professionals alike who are interested in groundbreaking advancements in brain health supplements. With BPC-157 (250 mcg) and Cognizin® Citicoline (250 mg), it has only 35 calories, is sugar-free and allergen-free, and comes individually wrapped for convenience.
To learn more about our Smart Chocolate BPC-157 with Cognizin® dietary supplement and its incredible benefits, visit infiniwell.com.
For media inquiries, please contact Giselle Chollett at [email protected] or 917.386.7116.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
About Cognizin® Citicoline: Cognizin® Citicoline, manufactured by Kyowa Hakko Bio Co., Ltd., is a clinically studied and branded form of Citicoline, a natural substance made endogenously in the body and especially vital to brain health. Citicoline is a potent brain-health nutrient. A proprietary form of citicoline, Cognizin® has been clinically studied to support mental energy, focus, attention, and recall. Cognizin® is manufactured through a fermentation process to yield high quality and high purity. Cognizin® is also highly stable, GRAS, ultra-pure, and allergen-free. For more information on Cognizin®, visit Cognizin.com.
About Kyowa Hakko, U.S.A.: Manufacturer of fermented amino acids and branded ingredients Kyowa Hakko U.S.A., Inc. is the North and South American office for KYOWA HAKKO BIO CO., LTD., an international ingredients manufacturer whose primary goal is to provide health solutions that support optimal health for improved quality of life. Pioneers in the development and application of patented fermentation technology, Kyowa’s ingredients meet the most demanding quality assurance standards currently in place within the U.S. dietary supplement, health food, cosmetic, and pharmaceutical industries. Kyowa Hakko U.S.A. represents a line of well-researched, branded ingredients and an extensive line of quality-assured, ultra-pure amino acids and related compounds.
About InfiniWell InfiniWell is committed to advancing human health through innovative, science-backed nutritional supplements. With a focus on leveraging the latest in scientific research, our mission is to provide products that support optimal health and longevity for our customers. For more information, visit infiniwell.com.
